Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1989. Upgrade now.
Date Value
September 30, 2024 7.993B
June 30, 2024 5.633B
March 31, 2024 3.657B
December 31, 2023 7.863B
September 30, 2023 7.489B
June 30, 2023 4.182B
March 31, 2023 3.257B
December 31, 2022 5.35B
September 30, 2022 6.284B
June 30, 2022 5.581B
March 31, 2022 3.979B
December 31, 2021 5.732B
September 30, 2021 8.29B
June 30, 2021 5.314B
March 31, 2021 4.074B
December 31, 2020 8.343B
September 30, 2020 8.383B
June 30, 2020 3.452B
March 31, 2020 3.358B
December 31, 2019 6.398B
September 30, 2019 7.527B
June 30, 2019 5.948B
March 31, 2019 3.543B
December 31, 2018 6.244B
September 30, 2018 6.272B
Date Value
June 30, 2018 6.079B
March 31, 2018 3.606B
December 31, 2017 6.105B
September 30, 2017 6.266B
June 30, 2017 5.772B
March 31, 2017 2.913B
December 31, 2016 6.653B
September 30, 2016 5.361B
June 30, 2016 4.564B
March 31, 2016 2.189B
December 31, 2015 5.085B
September 30, 2015 6.14B
June 30, 2015 5.472B
March 31, 2015 2.872B
December 31, 2014 4.604B
September 30, 2014 4.654B
June 30, 2014 5.529B
March 31, 2014 3.923B
December 31, 2013 4.139B
September 30, 2013 5.947B
June 30, 2013 5.051B
March 31, 2013 2.277B
December 31, 2012 3.376B
September 30, 2012 4.98B
June 30, 2012 4.245B

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

3.257B
Minimum
Mar 2023
8.383B
Maximum
Sep 2020
5.731B
Average
5.607B
Median

Cash from Operations (Quarterly) Benchmarks

Amgen Inc 3.571B
Eli Lilly and Co 3.712B
Merck & Co Inc 9.291B
Pfizer Inc 6.714B
AbbVie Inc 5.447B